{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:29:18Z","timestamp":1788348558104,"version":"build-2803163510"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-04951-4","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:26:09Z","timestamp":1772623569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Retinoblastoma: unveiling molecular pathogenesis and pioneering organoid-driven therapeutic innovations"],"prefix":"10.1186","volume":"17","author":[{"given":"Hua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenrui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"4951_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","volume":"379","author":"H Dimaras","year":"2012","unstructured":"Dimaras H, Kimani K, Dimba EAO, Gronsdahl P, White A, Chan HSL, et al. Retinoblastoma. Lancet. 2012;379:1436\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(11)61137-9.","journal-title":"Lancet"},{"key":"4951_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13090307","volume":"13","author":"A Kumari","year":"2025","unstructured":"Kumari A, Singh SP, Kumar P, Kondaveeti SB, Garg VK, Kaur R, et al. A comprehensive review of the epidemiology, pathophysiology, risk factors, and treatment strategies for retinoblastoma. Diseases. 2025;13:307. https:\/\/doi.org\/10.3390\/diseases13090307.","journal-title":"Diseases"},{"key":"4951_CR3","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMra1803083","volume":"390","author":"D Cobrinik","year":"2024","unstructured":"Cobrinik D. Retinoblastoma origins and destinations. N Engl J Med. 2024;390:1408\u201319. https:\/\/doi.org\/10.1056\/NEJMra1803083.","journal-title":"N Engl J Med"},{"key":"4951_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/1078-0432.CCR-21-1565","volume":"28","author":"AC Mandigo","year":"2022","unstructured":"Mandigo AC, Tomlins SA, Kelly WK, Knudsen KE. Relevance of pRB loss in human malignancies. Clin Cancer Res. 2022;28:255\u201364. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-1565.","journal-title":"Clin Cancer Res"},{"key":"4951_CR5","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.66.2.20","volume":"66","author":"Q Liao","year":"2025","unstructured":"Liao Q, Yang J, Shi H, Mengjiang R, Li Y, Zhang Q, et al. Aurora A kinase inhibition is synthetic lethal with the activation of MYCN in retinoblastoma. Invest Ophthalmol Vis Sci. 2025;66:20. https:\/\/doi.org\/10.1167\/iovs.66.2.20.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4951_CR6","doi-asserted-by":"publisher","first-page":"12368","DOI":"10.1111\/jcmm.15736","volume":"24","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhang P, Long C, Ma X, Huang H, Kuang X, et al. m6 a methyltransferase METTL3 promotes retinoblastoma progression via PI3K\/AKT\/mTOR pathway. J Cell Mol Med. 2020;24:12368\u201378. https:\/\/doi.org\/10.1111\/jcmm.15736.","journal-title":"J Cell Mol Med"},{"key":"4951_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/jcp.24141","volume":"228","author":"FP Fiorentino","year":"2013","unstructured":"Fiorentino FP, Marchesi I, Giordano A. On the role of retinoblastoma family proteins in the establishment and maintenance of the epigenetic landscape. J Cell Physiol. 2013;228:276\u201384. https:\/\/doi.org\/10.1002\/jcp.24141.","journal-title":"J Cell Physiol"},{"key":"4951_CR8","doi-asserted-by":"publisher","first-page":"33628","DOI":"10.1073\/pnas.2011780117","volume":"117","author":"H Liu","year":"2020","unstructured":"Liu H, Zhang Y, Zhang YY, Li YP, Hua ZQ, Zhang CJ, et al. Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin. Proc Natl Acad Sci U S A. 2020;117:33628\u201338. https:\/\/doi.org\/10.1073\/pnas.2011780117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4951_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ng1318","volume":"36","author":"J Zhang","year":"2004","unstructured":"Zhang J, Gray J, Wu L, Leone G, Rowan S, Cepko CL, et al. Rb regulates proliferation and rod photoreceptor development in the mouse retina. Nat Genet. 2004;36:351\u201360. https:\/\/doi.org\/10.1038\/ng1318.","journal-title":"Nat Genet"},{"key":"4951_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nprot.2011.429","volume":"7","author":"M Eiraku","year":"2011","unstructured":"Eiraku M, Sasai Y. Mouse embryonic stem cell culture for generation of three-dimensional retinal and cortical tissues. Nat Protoc. 2011;7:69\u201379. https:\/\/doi.org\/10.1038\/nprot.2011.429.","journal-title":"Nat Protoc"},{"key":"4951_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100444","volume":"2","author":"H Liu","year":"2021","unstructured":"Liu H, Hua ZQ, Jin ZB. Modeling human retinoblastoma using embryonic stem cell-derived retinal organoids. Star Protoc. 2021;2:100444. https:\/\/doi.org\/10.1016\/j.xpro.2021.100444.","journal-title":"Star Protoc"},{"key":"4951_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12015-023-10661-8","volume":"20","author":"H Zhao","year":"2024","unstructured":"Zhao H, Yan F. Retinal organoids: a next-generation platform for high-throughput drug discovery. Stem Cell Rev Rep. 2024;20:495\u2013508. https:\/\/doi.org\/10.1007\/s12015-023-10661-8.","journal-title":"Stem Cell Rev Rep"},{"key":"4951_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01278-4","volume":"15","author":"H Xu","year":"2022","unstructured":"Xu H, Jiao D, Liu A, Wu K. Tumor organoids: applications in cancer modeling and potentials in precision medicine. J Hematol Oncol. 2022;15:58. https:\/\/doi.org\/10.1186\/s13045-022-01278-4.","journal-title":"J Hematol Oncol"},{"key":"4951_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjo.2024.100058","volume":"13","author":"M Zhou","year":"2024","unstructured":"Zhou M, Tang J, Fan J, Wen X, Shen J, Jia R, et al. Recent progress in retinoblastoma: pathogenesis, presentation, diagnosis and management [presentation]. Asia Pac J Ophthalmol (Phila). 2024;13:100058. https:\/\/doi.org\/10.1016\/j.apjo.2024.100058.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"4951_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00234-024-03517-6","volume":"67","author":"Z Rumboldt","year":"2025","unstructured":"Rumboldt Z, Dodig D, Galluzzi P, Brumini I, Clarke R, Singh S, et al. Retinoblastoma and beyond: pediatric orbital mass lesions. Neuroradiology. 2025;67:469\u201392. https:\/\/doi.org\/10.1007\/s00234-024-03517-6.","journal-title":"Neuroradiology"},{"key":"4951_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04904-8","volume":"13","author":"C Wu","year":"2022","unstructured":"Wu C, Yang J, Xiao W, Jiang Z, Chen S, Guo D, et al. Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma. Cell Death Dis. 2022;13:438. https:\/\/doi.org\/10.1038\/s41419-022-04904-8.","journal-title":"Cell Death Dis"},{"key":"4951_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/35101031","volume":"1","author":"AG Knudson","year":"2001","unstructured":"Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer. 2001;1:157\u201362. https:\/\/doi.org\/10.1038\/35101031.","journal-title":"Nat Rev Cancer"},{"key":"4951_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215870","volume":"547","author":"Y Yao","year":"2022","unstructured":"Yao Y, Gu X, Xu X, Ge S, Jia R. Novel insights into RB1 mutation. Cancer Lett. 2022;547:215870. https:\/\/doi.org\/10.1016\/j.canlet.2022.215870.","journal-title":"Cancer Lett"},{"key":"4951_CR19","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nature08768","volume":"463","author":"GR Bignell","year":"2010","unstructured":"Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, et al. Signatures of mutation and selection in the cancer genome. Nature. 2010;463:893\u20138. https:\/\/doi.org\/10.1038\/nature08768.","journal-title":"Nature"},{"key":"4951_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/bs.pmbts.2015.06.012","volume":"134","author":"PR Mendoza","year":"2015","unstructured":"Mendoza PR, Grossniklaus HE. The biology of retinoblastoma. Prog Mol Biol Transl Sci. 2015;134:503\u201316. https:\/\/doi.org\/10.1016\/bs.pmbts.2015.06.012.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"4951_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ydbio.2020.03.011","volume":"462","author":"C Zheng","year":"2020","unstructured":"Zheng C, Schneider JW, Hsieh J. Role of RB1 in human embryonic stem cell-derived retinal organoids. Dev Biol. 2020;462:197\u2013207. https:\/\/doi.org\/10.1016\/j.ydbio.2020.03.011.","journal-title":"Dev Biol"},{"key":"4951_CR22","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.14.8","volume":"61","author":"D Saengwimol","year":"2020","unstructured":"Saengwimol D, Chittavanich P, Laosillapacharoen N, Srimongkol A, Chaitankar V, Rojanaporn D, et al. Silencing of the long noncoding RNA MYCNOS1 suppresses activity of MYCN-amplified retinoblastoma without RB1 mutation. Invest Ophthalmol Vis Sci. 2020;61:8. https:\/\/doi.org\/10.1167\/iovs.61.14.8.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4951_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/cam4.1010","volume":"6","author":"KG Ewens","year":"2017","unstructured":"Ewens KG, Bhatti TR, Moran KA, Richards-Yutz J, Shields CL, Eagle RC, et al. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma. Cancer Med. 2017;6:619\u201330. https:\/\/doi.org\/10.1002\/cam4.1010.","journal-title":"Cancer Med"},{"key":"4951_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06596-6","volume":"7","author":"T Ryl","year":"2024","unstructured":"Ryl T, Afanasyeva E, Hartmann T, Schwermer M, Schneider M, Schr\u00f6der C, et al. A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Commun Biol. 2024;7:919. https:\/\/doi.org\/10.1038\/s42003-024-06596-6.","journal-title":"Commun Biol"},{"key":"4951_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1172\/JCI88508","volume":"127","author":"N Wu","year":"2017","unstructured":"Wu N, Jia D, Bates B, Basom R, Eberhart CG, MacPherson D. A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence. J Clin Invest. 2017;127:888\u201398. https:\/\/doi.org\/10.1172\/JCI88508.","journal-title":"J Clin Invest"},{"key":"4951_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2217\/14796694.3.5.575","volume":"3","author":"R Godbout","year":"2007","unstructured":"Godbout R, Li L, Liu RZ, Roy K. Role of DEAD box 1 in retinoblastoma and neuroblastoma. Future Oncol. 2007;3:575\u201387. https:\/\/doi.org\/10.2217\/14796694.3.5.575.","journal-title":"Future Oncol"},{"key":"4951_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nrm1644","volume":"6","author":"VN Kim","year":"2005","unstructured":"Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6:376\u201385. https:\/\/doi.org\/10.1038\/nrm1644.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4951_CR28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.5114\/aoms.2019.86901","volume":"16","author":"J Li","year":"2020","unstructured":"Li J, Liu X, Wang W, Li C. miR-133a-3p promotes apoptosis and induces cell cycle arrest by targeting CREB1 in retinoblastoma. Arch Med Sci. 2020;16:941\u201356. https:\/\/doi.org\/10.5114\/aoms.2019.86901.","journal-title":"Arch Med Sci"},{"key":"4951_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/CMAR.S465183","volume":"16","author":"Z Song","year":"2024","unstructured":"Song Z, Wang H, Zong F, Zhu C, Tao Y. MicroRNA-506 regulates apoptosis in retinoblastoma cells by targeting sirtuin 1 [retraction]. Cancer Manag Res. 2024;16:113\u20134. https:\/\/doi.org\/10.2147\/CMAR.S465183.","journal-title":"Cancer Manag Res"},{"key":"4951_CR30","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3892\/etm.2018.7062","volume":"17","author":"D Zhao","year":"2019","unstructured":"Zhao D, Cui Z. MicroRNA-361-3p regulates retinoblastoma cell proliferation and stemness by targeting hedgehog signaling. Exp Ther Med. 2019;17:1154\u201362. https:\/\/doi.org\/10.3892\/etm.2018.7062.","journal-title":"Exp Ther Med"},{"key":"4951_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109111","volume":"118","author":"W Wan","year":"2019","unstructured":"Wan W, Wan W, Long Y, Li Q, Jin X, Wan G, et al. MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN\/Akt pathway. Biomed Pharmacother. 2019;118:109111. https:\/\/doi.org\/10.1016\/j.biopha.2019.109111.","journal-title":"Biomed Pharmacother"},{"key":"4951_CR32","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2020\/e1804","volume":"75","author":"Q Zheng","year":"2020","unstructured":"Zheng Q, Zhu Q, Li C, Hao S, Li J, Yu X, et al. microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma. Clinics. 2020;75:e1804.","journal-title":"Clinics"},{"key":"4951_CR33","doi-asserted-by":"publisher","first-page":"804","DOI":"10.7150\/jca.10456","volume":"5","author":"F Shen","year":"2014","unstructured":"Shen F, Mo MH, Chen L, An S, Tan X, Fu Y, et al. MicroRNA-21 down-regulates Rb1 expression by targeting PDCD4 in retinoblastoma. J Cancer. 2014;5:804\u201312. https:\/\/doi.org\/10.7150\/jca.10456.","journal-title":"J Cancer"},{"key":"4951_CR34","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.5.31","volume":"61","author":"C Zhang","year":"2020","unstructured":"Zhang C, Wu S. MicroRNA -378a-3p restrains the proliferation of retinoblastoma cells but promotes apoptosis of retinoblastoma cells via inhibition of FOXG1. Invest Ophthalmol Vis Sci. 2020;61:31. https:\/\/doi.org\/10.1167\/iovs.61.5.31.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4951_CR35","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","volume":"187","author":"LL Chen","year":"2024","unstructured":"Chen LL, Kim VN. Small and long non-coding RNAs: past, present, and future. Cell. 2024;187:6451\u201385. https:\/\/doi.org\/10.1016\/j.cell.2024.10.024.","journal-title":"Cell"},{"key":"4951_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.109340","volume":"226","author":"X Yan","year":"2023","unstructured":"Yan X, Jia H, Zhao J. LncRNA MEG3 attenuates the malignancy of retinoblastoma cells through inactivating PI3K\/Akt\/mTOR signaling pathway. Exp Eye Res. 2023;226:109340. https:\/\/doi.org\/10.1016\/j.exer.2022.109340.","journal-title":"Exp Eye Res"},{"key":"4951_CR37","first-page":"3111","volume":"12","author":"Y Gao","year":"2022","unstructured":"Gao Y, Chen X, Zhang J. LncRNA MEG3 inhibits retinoblastoma invasion and metastasis by inducing \u03b2-catenin degradation. Am J Cancer Res. 2022;12:3111\u201327.","journal-title":"Am J Cancer Res"},{"key":"4951_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1868-7083-5-3","volume":"5","author":"M Karahoca","year":"2013","unstructured":"Karahoca M, Momparler RL. Pharmacokinetic and pharmacodynamic analysis of 5-aza-2\u2019-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy. Clin Epigenetics. 2013;5:3. https:\/\/doi.org\/10.1186\/1868-7083-5-3.","journal-title":"Clin Epigenetics"},{"key":"4951_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25792-0","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Ottaviani D, Sefta M, Desbrousses C, Chapeaublanc E, Aschero R, et al. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal\/ganglion cell gene expression. Nat Commun. 2021;12:5578. https:\/\/doi.org\/10.1038\/s41467-021-25792-0.","journal-title":"Nat Commun"},{"key":"4951_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-025-10263-5","volume":"44","author":"R Pallavi","year":"2025","unstructured":"Pallavi R, Soni BL, Jha GK, Sanyal S, Fatima A, Kaliki S. Tumor heterogeneity in retinoblastoma: a literature review. Cancer Metastasis Rev. 2025;44:46. https:\/\/doi.org\/10.1007\/s10555-025-10263-5.","journal-title":"Cancer Metastasis Rev"},{"key":"4951_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656364","volume":"12","author":"K Khalaf","year":"2021","unstructured":"Khalaf K, Hana D, Chou JTT, Singh C, Mackiewicz A, Kaczmarek M. Aspects of the tumor microenvironment involved in immune resistance and drug resistance. Front Immunol. 2021;12:656364. https:\/\/doi.org\/10.3389\/fimmu.2021.656364.","journal-title":"Front Immunol"},{"key":"4951_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217737","volume":"624","author":"H Yuan","year":"2025","unstructured":"Yuan H, Qiu Y, Mei Z, Liu J, Wang L, Zhang K, et al. Cancer stem cells and tumor-associated macrophages: interactions and therapeutic opportunities. Cancer Lett. 2025;624:217737. https:\/\/doi.org\/10.1016\/j.canlet.2025.217737.","journal-title":"Cancer Lett"},{"key":"4951_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03986-0","volume":"12","author":"S Chen","year":"2021","unstructured":"Chen S, Chen X, Luo Q, Liu X, Wang X, Cui Z, et al. Retinoblastoma cell-derived exosomes promote angiogenesis of human vesicle endothelial cells through microRNA-92a-3p. Cell Death Dis. 2021;12:695. https:\/\/doi.org\/10.1038\/s41419-021-03986-0.","journal-title":"Cell Death Dis"},{"key":"4951_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000488709","volume":"5","author":"R Raguraman","year":"2019","unstructured":"Raguraman R, Parameswaran S, Kanwar JR, Khetan V, Rishi P, Kanwar RK, et al. Evidence of tumour microenvironment and stromal cellular components in retinoblastoma. Ocul Oncol Pathol. 2019;5:85\u201393. https:\/\/doi.org\/10.1159\/000488709.","journal-title":"Ocul Oncol Pathol"},{"key":"4951_CR45","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky JM, Garcia-Diaz A, Shin DS, Escuin-Ordinas H, Hugo W, Hu-Lieskovan S, et al. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N Engl J Med. 2016;375:819\u201329. https:\/\/doi.org\/10.1056\/NEJMoa1604958.","journal-title":"N Engl J Med"},{"key":"4951_CR46","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.molcel.2021.01.010","volume":"81","author":"M Yu","year":"2021","unstructured":"Yu M, Peng Z, Qin M, Liu Y, Wang J, Zhang C, et al. Interferon-\u03b3 induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation. Mol Cell. 2021;81:1216-1230.e9. https:\/\/doi.org\/10.1016\/j.molcel.2021.01.010.","journal-title":"Mol Cell"},{"key":"4951_CR47","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3892\/or.2020.7858","volume":"45","author":"S Chen","year":"2021","unstructured":"Chen S, Chen X, Qiu J, Chen P, Han X, Wu Y, et al. Exosomes derived from retinoblastoma cells enhance tumour deterioration by infiltrating the microenvironment. Oncol Rep. 2021;45:278\u201390. https:\/\/doi.org\/10.3892\/or.2020.7858.","journal-title":"Oncol Rep"},{"key":"4951_CR48","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.32604\/or.2025.059657","volume":"33","author":"M Nakashima","year":"2025","unstructured":"Nakashima M, Suga N, Fukumoto A, Yoshikawa S, Matsuda S. Promising roles of Vitamin D receptor and APRO family proteins for the development of cancer stem cells targeted malignant tumor therapy. Oncol Res. 2025;33:1007\u201317. https:\/\/doi.org\/10.32604\/or.2025.059657.","journal-title":"Oncol Res"},{"key":"4951_CR49","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1002\/cncr.25059","volume":"116","author":"Y Ma","year":"2010","unstructured":"Ma Y, Yu WD, Trump DL, Johnson CS. 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models. Cancer. 2010;116:3294\u2013303. https:\/\/doi.org\/10.1002\/cncr.25059.","journal-title":"Cancer"},{"key":"4951_CR50","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2174\/1566524020666200925160015","volume":"21","author":"A Ahmad","year":"2021","unstructured":"Ahmad A, Ansari IA. A comprehensive review on cross-talk of human papilloma virus oncoproteins and developmental\/self-renewal pathways during the pathogenesis of uterine cervical cancer. Curr Mol Med. 2021;21:402\u201316. https:\/\/doi.org\/10.2174\/1566524020666200925160015.","journal-title":"Curr Mol Med"},{"key":"4951_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108479","volume":"248","author":"CR Croley","year":"2023","unstructured":"Croley CR, Pumarol J, Delgadillo BE, Cook AC, Day F, Kaceli T, et al. Signaling pathways driving ocular malignancies and their targeting by bioactive phytochemicals. Pharmacol Ther. 2023;248:108479. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108479.","journal-title":"Pharmacol Ther"},{"key":"4951_CR52","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.tibs.2008.08.002","volume":"33","author":"M Yee Koh","year":"2008","unstructured":"Yee Koh M, Spivak-Kroizman TR, Powis G. HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci. 2008;33:526\u201334. https:\/\/doi.org\/10.1016\/j.tibs.2008.08.002.","journal-title":"Trends Biochem Sci"},{"key":"4951_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108887","volume":"214","author":"N Zhao","year":"2022","unstructured":"Zhao N, Zhou L, Lu Q, Wang S, Sun Y, Ding Y, et al. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo\/YAP signaling pathway. Exp Eye Res. 2022;214:108887. https:\/\/doi.org\/10.1016\/j.exer.2021.108887.","journal-title":"Exp Eye Res"},{"key":"4951_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-023-00529-w","volume":"17","author":"L Markovi\u0107","year":"2023","unstructured":"Markovi\u0107 L, Bukovac A, Varo\u0161anec AM, \u0160laus N, Pe\u0107ina-\u0160laus N. Genetics in ophthalmology: molecular blueprints of retinoblastoma. Hum Genomics. 2023;17:82. https:\/\/doi.org\/10.1186\/s40246-023-00529-w.","journal-title":"Hum Genomics"},{"key":"4951_CR55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccell.2018.03.023","volume":"34","author":"ME Klein","year":"2018","unstructured":"Klein ME, Kovatcheva M, Davis LE, Tap WD, Koff A. CDK4\/6 inhibitors: the mechanism of action may not be as simple as once thought. Cancer Cell. 2018;34:9\u201320. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.023.","journal-title":"Cancer Cell"},{"key":"4951_CR56","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","volume":"29","author":"K Engeland","year":"2022","unstructured":"Engeland K. Cell cycle regulation: p53-p21-RB signaling. Cell Death Differ. 2022;29:946\u201360. https:\/\/doi.org\/10.1038\/s41418-022-00988-z.","journal-title":"Cell Death Differ"},{"key":"4951_CR57","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/kjm2.12469","volume":"38","author":"W Yang","year":"2022","unstructured":"Yang W, Jiang XX, Zhao XY, Mao PA. Treatment of RB-deficient retinoblastoma with Aurora-A kinase inhibitor. Kaohsiung J Med Sci. 2022;38:244\u201352. https:\/\/doi.org\/10.1002\/kjm2.12469.","journal-title":"Kaohsiung J Med Sci"},{"key":"4951_CR58","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.survophthal.2024.05.009","volume":"69","author":"VS Vempuluru","year":"2024","unstructured":"Vempuluru VS, Maniar A, Bakal K, Kaliki S. Role of MYCN in retinoblastoma: a review of current literature. Surv Ophthalmol. 2024;69:697\u2013706. https:\/\/doi.org\/10.1016\/j.survophthal.2024.05.009.","journal-title":"Surv Ophthalmol"},{"key":"4951_CR59","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.trecan.2016.07.007","volume":"2","author":"J Gingold","year":"2016","unstructured":"Gingold J, Zhou R, Lemischka IR, Lee DF. Modeling cancer with pluripotent stem cells. Trends Cancer. 2016;2:485\u201394. https:\/\/doi.org\/10.1016\/j.trecan.2016.07.007.","journal-title":"Trends Cancer"},{"key":"4951_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-020-0237-8","volume":"6","author":"A Aubry","year":"2020","unstructured":"Aubry A, Yu T, Bremner R. Preclinical studies reveal MLN4924 is a promising new retinoblastoma therapy. Cell Death Discov. 2020;6:2. https:\/\/doi.org\/10.1038\/s41420-020-0237-8.","journal-title":"Cell Death Discov"},{"key":"4951_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04431-y","volume":"12","author":"Y Mao","year":"2021","unstructured":"Mao Y, Sun Y, Wu Z, Zheng J, Zhang J, Zeng J, et al. Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy. Cell Death Dis. 2021;12:1141. https:\/\/doi.org\/10.1038\/s41419-021-04431-y.","journal-title":"Cell Death Dis"},{"key":"4951_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081558","volume":"16","author":"MF Huang","year":"2024","unstructured":"Huang MF, Wang YX, Chou YT, Lee DF. Therapeutic strategies for RB1-deficient cancers: intersecting gene regulation and targeted therapy. Cancers (Basel). 2024;16:1558. https:\/\/doi.org\/10.3390\/cancers16081558.","journal-title":"Cancers (Basel)"},{"key":"4951_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-024-00387-7","volume":"9","author":"N Zhao","year":"2024","unstructured":"Zhao N, Zhang CJ, Zhang X, Wang W, Jin K, Jin ZB. Transplantation of derivative retinal organoids from chemically induced pluripotent stem cells restored visual function. NPJ Regen Med. 2024;9:42. https:\/\/doi.org\/10.1038\/s41536-024-00387-7.","journal-title":"NPJ Regen Med"},{"key":"4951_CR64","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41588-022-01147-3","volume":"54","author":"FJ Rouhani","year":"2022","unstructured":"Rouhani FJ, Zou X, Danecek P, Badja C, Amarante TD, Koh G, et al. Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells. Nat Genet. 2022;54:1406\u201316. https:\/\/doi.org\/10.1038\/s41588-022-01147-3.","journal-title":"Nat Genet"},{"key":"4951_CR65","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1126\/science.1239278","volume":"341","author":"P Hou","year":"2013","unstructured":"Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science. 2013;341:651\u20134. https:\/\/doi.org\/10.1126\/science.1239278.","journal-title":"Science"},{"key":"4951_CR66","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.trecan.2025.03.005","volume":"11","author":"SY Kim","year":"2025","unstructured":"Kim SY, van de Wetering M, Clevers H, Sanders K. The future of tumor organoids in precision therapy. Trends Cancer. 2025;11:665\u201375. https:\/\/doi.org\/10.1016\/j.trecan.2025.03.005.","journal-title":"Trends Cancer"},{"key":"4951_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43746-6","volume":"14","author":"N Li","year":"2023","unstructured":"Li N, Zhu Q, Tian Y, Ahn KJ, Wang X, Cramer Z, et al. Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment. Nat Commun. 2023;14:7915. https:\/\/doi.org\/10.1038\/s41467-023-43746-6.","journal-title":"Nat Commun"},{"key":"4951_CR68","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, et al. Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell. 2018;174:1586-1598.e12. https:\/\/doi.org\/10.1016\/j.cell.2018.07.009.","journal-title":"Cell"},{"key":"4951_CR69","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2353\/ajpath.2010.090512","volume":"177","author":"XL Xu","year":"2010","unstructured":"Xu XL, Lee TC, Offor N, Cheng C, Liu A, Fang Y, et al. Tumor-associated retinal astrocytes promote retinoblastoma cell proliferation through production of IGFBP-5. Am J Pathol. 2010;177:424\u201335. https:\/\/doi.org\/10.2353\/ajpath.2010.090512.","journal-title":"Am J Pathol"},{"key":"4951_CR70","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/path.5893","volume":"257","author":"M Cuadrado-Vilanova","year":"2022","unstructured":"Cuadrado-Vilanova M, Liu J, Paco S, Aschero R, Burgue\u00f1o V, Sirab N, et al. Identification of immunosuppressive factors in retinoblastoma cell secretomes and aqueous humor from patients. J Pathol. 2022;257:327\u201339. https:\/\/doi.org\/10.1002\/path.5893.","journal-title":"J Pathol"},{"key":"4951_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108067","volume":"197","author":"R Raguraman","year":"2020","unstructured":"Raguraman R, Parameswaran S, Kanwar JR, Vasudevan M, Chitipothu S, Kanwar RK, et al. Gene expression profiling of tumor stroma interactions in retinoblastoma. Exp Eye Res. 2020;197:108067. https:\/\/doi.org\/10.1016\/j.exer.2020.108067.","journal-title":"Exp Eye Res"},{"key":"4951_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07285-2","volume":"15","author":"E Alefeld","year":"2024","unstructured":"Alefeld E, Haase A, Van Meenen D, Budeus B, Dr\u00e4ger O, Miroschnikov N, et al. In vitro model of retinoblastoma derived tumor and stromal cells for tumor microenvironment (TME) studies. Cell Death Dis. 2024;15:905. https:\/\/doi.org\/10.1038\/s41419-024-07285-2.","journal-title":"Cell Death Dis"},{"key":"4951_CR73","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","volume":"173","author":"SH Lee","year":"2018","unstructured":"Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, et al. Tumor evolution and drug response in patient-derived organoid models of bladder. Cancer Cell. 2018;173:515-28.e17.","journal-title":"Cancer Cell"},{"key":"4951_CR74","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.stemcr.2017.11.001","volume":"10","author":"T DiStefano","year":"2018","unstructured":"DiStefano T, Chen HY, Panebianco C, Kaya KD, Brooks MJ, Gieser L, et al. Accelerated and improved differentiation of retinal organoids from pluripotent stem cells in rotating-wall vessel bioreactors. Stem Cell Reports. 2018;10:300\u201313. https:\/\/doi.org\/10.1016\/j.stemcr.2017.11.001.","journal-title":"Stem Cell Reports"},{"key":"4951_CR75","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1007\/s00432-021-03814-0","volume":"147","author":"SM Bhat","year":"2021","unstructured":"Bhat SM, Badiger VA, Vasishta S, Chakraborty J, Prasad S, Ghosh S, et al. 3D tumor angiogenesis models: Recent advances and challenges. J Cancer Res Clin Oncol. 2021;147:3477\u201394. https:\/\/doi.org\/10.1007\/s00432-021-03814-0.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4951_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02977-3","volume":"5","author":"M Cipriano","year":"2022","unstructured":"Cipriano M, Schl\u00fcnder K, Probst C, Linke K, Weiss M, Fischer MJ, et al. Human immunocompetent choroid-on-chip: A novel tool for studying ocular effects of biological drugs. Commun Biol. 2022;5:52. https:\/\/doi.org\/10.1038\/s42003-021-02977-3.","journal-title":"Commun Biol"},{"key":"4951_CR77","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1167\/iovs.16-20796","volume":"58","author":"AW Browne","year":"2017","unstructured":"Browne AW, Arnesano C, Harutyunyan N, Khuu T, Martinez JC, Pollack HA, et al. Structural and functional characterization of human stem-cell-derived retinal organoids by live imaging. Invest Ophthalmol Vis Sci. 2017;58:3311\u20138. https:\/\/doi.org\/10.1167\/iovs.16-20796.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4951_CR78","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.bioactmat.2020.10.003","volume":"6","author":"C Chen","year":"2021","unstructured":"Chen C, Rengarajan V, Kjar A, Huang Y. A Matrigel-free method to generate matured human cerebral organoids using 3D-Printed microwell arrays. Bioact Mater. 2021;6:1130\u20139. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.10.003.","journal-title":"Bioact Mater"},{"key":"4951_CR79","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/acc761","author":"X Sun","year":"2023","unstructured":"Sun X, Cui Z, Liang Y, Duan C, Chan HF, Mao S, et al. One-stop assembly of adherent 3D retinal organoids from hiPSCs based on 3D-printed derived PDMS microwell platform. Biofabrication. 2023. https:\/\/doi.org\/10.1088\/1758-5090\/acc761.","journal-title":"Biofabrication"},{"key":"4951_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtos.2020.11.004","volume":"19","author":"N Manafi","year":"2021","unstructured":"Manafi N, Shokri F, Achberger K, Hirayama M, Mohammadi MH, Noorizadeh F, et al. Organoids and organ chips in ophthalmology. Ocul Surf. 2021;19:1\u201315. https:\/\/doi.org\/10.1016\/j.jtos.2020.11.004.","journal-title":"Ocul Surf"},{"key":"4951_CR81","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/stcltm\/szac008","volume":"11","author":"A Rozanska","year":"2022","unstructured":"Rozanska A, Cerna-Chavez R, Queen R, Collin J, Zerti D, Dorgau B, et al. pRB-depleted pluripotent stem cell retinal organoids recapitulate cell state transitions of retinoblastoma development and suggest an important role for pRB in retinal cell differentiation. Stem Cells Transl Med. 2022;11:415\u201333. https:\/\/doi.org\/10.1093\/stcltm\/szac008.","journal-title":"Stem Cells Transl Med"},{"key":"4951_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24781-7","volume":"12","author":"JL Norrie","year":"2021","unstructured":"Norrie JL, Nityanandam A, Lai K, Chen X, Wilson M, Stewart E, et al. Retinoblastoma from human stem cell-derived retinal organoids. Nat Commun. 2021;12:4535. https:\/\/doi.org\/10.1038\/s41467-021-24781-7.","journal-title":"Nat Commun"},{"key":"4951_CR83","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/glia.24507","volume":"72","author":"J Xu","year":"2024","unstructured":"Xu J, Yu SJ, Sun S, Li YP, Zhang X, Jin K, et al. Enhanced innate responses in microglia derived from retinoblastoma patient-specific iPSCs. Glia. 2024;72:872\u201384. https:\/\/doi.org\/10.1002\/glia.24507.","journal-title":"Glia"},{"key":"4951_CR84","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-024-09564-9","volume":"51","author":"A Vincent","year":"2024","unstructured":"Vincent A, Krishnakumar S, Parameswaran S. Heterozygous RB1 mutation enhanced ATP production in human iPSC-derived retinal organoids. Mol Biol Rep. 2024;51:606. https:\/\/doi.org\/10.1007\/s11033-024-09564-9.","journal-title":"Mol Biol Rep"},{"key":"4951_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2017.05.064","volume":"27","author":"NJ Vickers","year":"2017","unstructured":"Vickers NJ. Animal communication: When I\u2019m calling you, will you answer too? Curr Biol. 2017;27:R713\u20135. https:\/\/doi.org\/10.1016\/j.cub.2017.05.064.","journal-title":"Curr Biol"},{"key":"4951_CR86","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/stem.3379","volume":"39","author":"L Shariati","year":"2021","unstructured":"Shariati L, Esmaeili Y, Haghjooy Javanmard S, Bidram E, Amini A. Organoid technology: current standing and future perspectives. Stem Cells. 2021;39:1625\u201349. https:\/\/doi.org\/10.1002\/stem.3379.","journal-title":"Stem Cells"},{"key":"4951_CR87","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/stcltm\/szab010","volume":"11","author":"B Dorgau","year":"2022","unstructured":"Dorgau B, Georgiou M, Chaudhary A, Moya-Molina M, Collin J, Queen R, et al. Human retinal organoids provide a suitable tool for toxicological investigations: a comprehensive validation using drugs and compounds affecting the retina. Stem Cells Transl Med. 2022;11:159\u201377. https:\/\/doi.org\/10.1093\/stcltm\/szab010.","journal-title":"Stem Cells Transl Med"},{"key":"4951_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202001531","volume":"9","author":"H Ragelle","year":"2020","unstructured":"Ragelle H, Dernick K, Khemais S, Keppler C, Cousin L, Farouz Y, et al. Human retinal microvasculature-on-a-chip for drug discovery. Adv Healthc Mater. 2020;9:e2001531. https:\/\/doi.org\/10.1002\/adhm.202001531.","journal-title":"Adv Healthc Mater"},{"key":"4951_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114842","volume":"197","author":"J Yu","year":"2023","unstructured":"Yu J, Yin Y, Leng Y, Zhang J, Wang C, Chen Y, et al. Emerging strategies of engineering retinal organoids and organoid-on-a-chip in modeling intraocular drug delivery: current progress and future perspectives. Adv Drug Deliv Rev. 2023;197:114842. https:\/\/doi.org\/10.1016\/j.addr.2023.114842.","journal-title":"Adv Drug Deliv Rev"},{"key":"4951_CR90","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s12072-021-10237-z","volume":"15","author":"G Ramakrishna","year":"2021","unstructured":"Ramakrishna G, Babu PE, Singh R, Trehanpati N. Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids. Hepatol Int. 2021;15:1309\u201317. https:\/\/doi.org\/10.1007\/s12072-021-10237-z.","journal-title":"Hepatol Int"},{"key":"4951_CR91","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00471","volume":"2","author":"M Jinek","year":"2013","unstructured":"Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J. RNA-programmed genome editing in human cells. Elife. 2013;2:e00471. https:\/\/doi.org\/10.7554\/eLife.00471.","journal-title":"Elife"},{"key":"4951_CR92","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.omtm.2023.05.012","volume":"29","author":"TAV Afanasyeva","year":"2023","unstructured":"Afanasyeva TAV, Athanasiou D, Perdigao PRL, Whiting KR, Duijkers L, Astuti GDN, et al. CRISPR-Cas9 correction of a nonsense mutation in LCA5 rescues lebercilin expression and localization in human retinal organoids. Mol Ther Methods Clin Dev. 2023;29:522\u201331. https:\/\/doi.org\/10.1016\/j.omtm.2023.05.012.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4951_CR93","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.stemcr.2021.09.007","volume":"16","author":"KR Chirco","year":"2021","unstructured":"Chirco KR, Chew S, Moore AT, Duncan JL, Lamba DA. Allele-specific gene editing to rescue dominant CRX-associated LCA7 phenotypes in a retinal organoid model. Stem Cell Reports. 2021;16:2690\u2013702. https:\/\/doi.org\/10.1016\/j.stemcr.2021.09.007.","journal-title":"Stem Cell Reports"},{"key":"4951_CR94","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.190010","volume":"9","author":"E Ikeda","year":"2019","unstructured":"Ikeda E, Ogawa M, Takeo M, Tsuji T. Functional ectodermal organ regeneration as the next generation of organ replacement therapy. Open Biol. 2019;9:190010. https:\/\/doi.org\/10.1098\/rsob.190010.","journal-title":"Open Biol"},{"key":"4951_CR95","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s11427-023-2531-3","volume":"67","author":"CJ Zhang","year":"2024","unstructured":"Zhang CJ, Jin ZB. Turning point of organoid transplantation: first-in-human trial of iPSC-derived retinal organoid grafting in patients with retinitis pigmentosa. Sci China Life Sci. 2024;67:1082\u20134. https:\/\/doi.org\/10.1007\/s11427-023-2531-3.","journal-title":"Sci China Life Sci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-04951-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04951-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04951-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:27:05Z","timestamp":1772702825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-04951-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4951"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-04951-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}